← GMP Foundations course overview
GMP Deviations, Investigations and CAPA
Lesson 1.8 · Narrated learning · Optional captions and key explanations
Video and companion reading: The supplementary written sections below expand on the recorded lesson and may include later technical or regulatory clarifications. They are not necessarily narrated in the video. For the most complete learning experience, study both the video and the companion reading. Regulatory references are provided for educational use and should be checked against the current official text.
Turn captions and key explanations on or off using the controls above.
Supplementary reading: Deviations, investigations and CAPA
Deviation: Record departures from approved processes or expected conditions promptly, contain any immediate risk, preserve evidence and assess potential impact on product quality. Investigation depth should be proportionate to risk and follow approved procedures.
CAPA: Corrective action addresses identified causes of an existing issue; preventive action seeks to prevent potential problems. Root-cause analysis, action ownership, deadlines and effectiveness verification should be appropriate to the investigation. Not every event necessarily requires a separate CAPA, but its disposition must be justified and documented.
Practical example: After a differential-pressure excursion, preserve monitoring trends and alarm records, document the affected time and activities, assess environmental and product impact, and determine whether corrective actions or further investigation are needed.
Regulatory context: US 21 CFR 211.192 addresses review and investigation of unexplained discrepancies and specification failures. EU GMP Volume 4 Chapter 1 addresses the pharmaceutical quality system, including deviation management and CAPA principles. ICH Q9(R1) provides quality-risk-management guidance, not an exemption from GMP obligations.
21 CFR 211.192 · EU GMP Volume 4 · ICH Quality Guidelines
Additional written learning material; not included in the existing video narration.
Readable guide to the video diagrams
Text descriptions of the main slide relationships, in presentation order. Use these with the narration transcript and companion reading. Arrows summarize relationships; they do not replace site procedures or prescribe a universal workflow. The repeated right-hand panels are reminders, not additional mandatory steps.
- Deviation management: detect, assess and prevent recurrence.
- Containment: stop or secure as appropriate, segregate and preserve evidence; report under site procedures.
- Deviation record: what, when and where; affected material; immediate action.
- Root-cause investigation considers people, process and equipment. The corrected slide says investigate root causes.
- Product impact review considers batch scope, risk evidence and disposition.
- CAPA links correction and prevention to demonstrated causes, assigned owners and verified implementation.
- Effectiveness review: implement, monitor, trend and verify that controls work.
- Pressure alarm example: report, preserve, assess and verify. A return to normal does not erase the event.
Read the recorded narration transcript
This transcript follows the existing recording. Read the technical clarifications and companion material as well.
00:00:00 Deviations are departures from approved procedures,
00:00:03 established processes or expected conditions.
00:00:06 A robust pharmaceutical quality system encourages
00:00:09 prompt reporting and proportionate investigation.
00:00:13 The purpose is to understand what happened, assess potential product impact
00:00:17 and prevent recurrence. Corrective and preventive action, or C A P
00:00:22 A, is one possible output of a documented investigation.
00:00:27 When an unexpected event is detected, personnel should first protect people,
00:00:32 product and evidence as appropriate to the situation. This may require
00:00:36 stopping an activity, segregating affected materials or placing a batch on
00:00:41 hold under approved procedures. Immediate containment
00:00:44 controls the potential consequences while
00:00:47 the quality assessment continues. Personnel must not silently correct or conceal an event.
00:00:54 Deviation records should capture what happened, when and where it occurred,
00:00:59 the affected equipment or materials, and the immediate actions taken. Classification
00:01:03 and investigation depth should reflect risk, potential impact and site procedures.
00:01:10 Records should distinguish observed facts from assumptions. Clear contemporaneous documentation supports
00:01:16 reliable evaluation and later review.
00:01:20 Root cause investigation seeks to explain why a deviation occurred, not
00:01:24 simply identify who was present. Teams may use a timeline, process
00:01:29 mapping, the five whys or a cause-and-effect diagram when suitable. Potential
00:01:34 causes should be tested against available evidence. Human error alone is
00:01:39 rarely an adequate explanation if procedure design, training, equipment or working
00:01:45 conditions contributed.
00:01:47 Product impact assessment considers the affected
00:01:49 materials, batches, processes, time window
00:01:53 and available supporting data. The assessment should be scientifically justified and
00:01:58 documented by authorized personnel. It may
00:02:01 require additional investigation or testing,
00:02:04 but testing alone cannot always establish that a process deviation had
00:02:09 no impact. Final disposition follows applicable
00:02:12 procedures and regulatory requirements.
00:02:15 A correction addresses an identified problem, while a corrective action aims
00:02:20 to remove its cause and prevent recurrence. Preventive actions may address
00:02:25 potential problems before they occur. Actions should have clear ownership, due
00:02:30 dates and documented implementation. Retraining may be appropriate in some cases,
00:02:35 but should not be the default response without understanding the underlying cause.
00:02:40 CAPA effectiveness should be evaluated using measures suited to the identified
00:02:44 cause and risk. Examples include observing
00:02:48 process performance, reviewing repeat events
00:02:50 or verifying that a new control works as intended. Trend analysis
00:02:55 can identify recurring deviations that
00:02:58 individual investigations miss. An action should
00:03:01 not be declared effective solely because it was completed on schedule.
00:03:06 Imagine a filling-line differential pressure alarm that occurred during production and
00:03:10 was not promptly documented. The event should be reported, relevant records
00:03:15 preserved and the affected period assessed. Authorized personnel should investigate the
00:03:20 alarm, the response and potential product impact. CAPA, if needed, should
00:03:25 address the demonstrated causes, with effectiveness checks. A return to normal
00:03:30 pressure does not erase the original deviation.
Check your understanding
What should happen after a differential pressure alarm occurs during filling?